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Abstract
Background: Around 80%  of intrauterine growth restricted (IUGR) infants are born at term. 
They have an increase in perinatal mortality and morbidity including behavioral problems, minor 
developmental delay and spastic cerebral palsy. Management is controversial, in particular the 
decision whether to induce labour or await spontaneous delivery with strict fetal and maternal 
surveillance. W e  propose a randomised trial to compare effectiveness, costs and maternal quality
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of life for induction of labour versus expectant management in women with a suspected IU G R  fetus 
at term.
Methods/design: The proposed trial is a multi-centre randomised study in pregnant women who 
are suspected on clinical grounds of having an IU G R  child at a gestational age between 36+0 and 
41+0 weeks. After informed consent women will be randomly allocated to either induction of 
labour or expectant management with maternal and fetal monitoring. Randomisation will be web- 
based. The primary outcome measure will be a composite neonatal morbidity and mortality. 
Secondary outcomes will be severe maternal morbidity, maternal quality of life and costs. 
Moreover, we aim to assess neurodevelopmental and neurobehavioral outcome at two years as 
assessed by a postal enquiry (Child Behavioral Check List-CBCL and Ages and Stages 
Questionnaire-ASQ). Analysis will be by intention to treat. Quality of life analysis and a preference 
study will also be performed in the same study population. Health technology assessment with an 
economic analysis is part of this so called Digitat trial (Disproportionate Intrauterine Growth 
Intervention Trial A t Term). The study aims to include 325 patients per arm.
Discussion: This trial will provide evidence for which strategy is superior in terms of neonatal and 
maternal morbidity and mortality, costs and maternal quality of life aspects. This will be the first 
randomised trial for IU G R  at term.
T ria l registration: Dutch Trial Register and ISRCTN-Register: ISR C T N I03632 I7 .
Background
Around 80% of intrauterine growth restricted (IUGR) 
infants are born at term [1]. When pregnancy is compli­
cated by IUGR, there is, whether term or preterm, a clear 
association with an increase in neonatal mortality and 
neonatal morbidity (short and long term) [2-4]. The long 
term morbidity ranges from behavioral problems and 
m inor developmental delay to spastic cerebral palsy [5­
10]. However, not all studies, especially after excluding 
congenital anomalies, confirm these findings [11]. 
Besides fetal asphyxia, meconium aspiration, fetal heart 
rate abnormalities and low Apgar score, also more admit­
tances to and longer stays at neonatal intensive care units 
are reported. This might partly be related to a higher prev­
alence of hypoglycaemia, neonatal sepsis, hypothermia 
and haematological problems as thrombocytopenia and 
polycythemia in these neonates [12-14].
When a fetus is small for gestational age (SGA), defined 
on the basis of a birth weight below the 10th centile, there 
is the concern that the fetus might be afflicted by IUGR 
[15]. As SGA is defined on the basis of an arbitrary chosen 
cutoff birth weight centile, not all infants falling below the 
10th centile are abnormally small because of growth 
restriction. Many neonates with a birth weight below the 
10th centile are representing the normal spectrum of fetal 
growth [11]. Variation in birth weight is related to many 
factors as maternal height, weight, parity and fetal gender, 
but also ethnicity [16]. For that reason optimal growth for 
any fetus should be related to the fetus' own individual 
optimal growth curve [17-19]. Intrauterine growth restric­
tion has to be defined on further knowledge such as Dop­
pler abnormalities as seen in placental perfusion,
eventually in combination with abnormalities in cerebral 
perfusion [20,21] and possibly also by neonatal measure­
ments as the Ponderal Index [22,23].
A reduction of fetal growth is exponentially associated 
with a higher perinatal mortality [24] and morbidity 
[25,26]. Doppler umbilical artery studies have shown that 
absence of end diastolic velocities, indicative of IUGR 
based on severe placental insufficiency is associated with 
a higher rate of caesarean deliveries and an increased inci­
dence of perinatal and neonatal mortality [27-30]. How­
ever, a normal umbilical artery Doppler study at term 
gestation might be falsely reassuring, while a normal cer­
ebral artery study might identify the fetus not likely hav­
ing a major adverse outcome [31].
Most of the growth restricted children experience an accel­
erated growth, especially of the head circumference, dur­
ing the first 6 months after birth [32]. However, this 
upward centile crossing or 'catch up growth' is not com­
plete, even at the age of seven years [33]. Moreover head 
circumference seems to correlate with cognitive outcome 
[34].
Long-term neurological and cognitive development of the 
IUGR infant at term have been studied extensively. The 
Ponderal Index among IUGR infants, but also among 
infants with a normal birth weight, is an independent pre­
dictor of neonatal morbidity: the lower the Ponderal 
Index the higher morbidity [25]. Learning difficulties, 
defects in speech and m ild neurological deficits and 
behavioral problems have been reported to occur more in 
term neonates born SGA [35,36]. At school ages (7-8
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years) temperamental differences and differences in play 
behavior are apparent [37], m ost probably contributing to 
increased rate of school failure found in IUGR infants.
Long-term morbidity might be resulting from subtle 
nutritional insults to the brain in utero. Although the 
brain growth spurt, being the most vulnerable period of 
the hum an brain, spans a broad period between m id preg­
nancy and 6 months of postnatal age [38,39], it is shown 
that growth failure occurring around term shows a strong 
association with cognitive disturbances as a poorer mental 
and psychomotor development at two years of age [40]. 
However, not all studies, even at preschool age show this 
trend of increased problems in growth restricted infants 
[41,42]. Besides neurodevelopmental consequences it is 
now also clear that children who were undernourished 
during pregnancy (e.g. born with a birth weight more than 
2 SD below the mean birth weight) and especially in com­
bination having had a compensatory growth trajectory 
during childhood have an increased risk in later life for 
diabetes, hypertension and cardiovascular diseases [43].
Given the data from studies concerning the effect of 
under-nutrition on the brain and the effects on long-term 
cognitive and behavioral outcome, evaluation of the pos­
sible clinical benefit of early induction of delivery, pre­
empting a detrimental effect of chronic under nutrition 
on the fetal brain intervention, is important. By such an 
intervention it might be possible to start earlier with a 
more optimal feeding, compensating for the poor intra­
uterine environment. Induction of labor is very often 
common practice in cases of suspected IUGR [44,45]. In 
the Netherlands at 33 up to 36 weeks of gestation, 63% of 
IUGR pregnancies were induced, whereas from 37 weeks 
onwards this percentage is 23%; more than double the 
percentage in non-IUGR pregnancies. In a Dutch obstetric 
cohort of 14.294 primigravid women with IUGR pregnan­
cies, 29% of these pregnancies were induced [46]. In these 
pregnancies complicated by IUGR, induction of labour 
was associated with an increased risk of instrumental 
deliveries and emergency caesarean section, but no differ­
ence in neonatal outcome immediately after birth was 
found.
At present, there is no uniformity on the management of 
women with IUGR at term. Although there is no doubt 
that the intra-uterine growth retardated fetus should be 
considered as high risk, and should be monitored, there is 
no consensus on which diagnostic methods to evaluate 
fetal condition and subsequent intervention is best. It is 
unclear whether in this situation either induction of 
labour or expectant management is beneficial for the 
m other and her baby, since evidence on the subject is 
lacking.
For preterm pregnancies complicated by intra-uterine 
growth retardation, an international randomised clinical 
trial recently showed that expectant management had lit­
tle benefit over early delivery with respect to short term 
neonatal outcome [47]. However, results of this trial can­
not be extrapolated to the situation at term.
The lack of consensus on the subject in the Netherlands is 
demonstrated by the fact that in 2002 in women with a 
SGA child, labour was induced in 32% of these women, 
whereas labour started spontaneously in 56% of these 
women, the remaining 11% had an elective caesarean sec­
tion. These data are based on actual birth weight, and the 
clinical situation is even more complicated by the fact that 
the antenatal diagnosis of a SGA child is often difficult to 
make and easily missed in clinical practice.
In view of this clinical dilemma, we propose a ran­
domised clinical trial in which induction of labour is 
compared with expectant monitoring in women with a 
suspected IUGR child at term. We will compare maternal 
outcome, neonatal outcome and maternal quality of life, 
as well as costs. Moreover, we will collect, in both ran­
domisation arms, data of the diagnostic tests used in fetal 
surveillance, i.e. fetal heart rate pattern, sonographic 
measurement of the amniotic fluid index and Doppler 
measurement of the umbilical artery and the fetal medial 
cerebral artery in women.
Methods/design
Aims
The aim of this study is to investigate whether induction 
of labour or expectant management is the best strategy in 
terms of neonatal and maternal morbidity and mortality, 
costs and maternal quality of life aspect in pregnancies 
complicated by IUGR from 36 weeks gestational weeks 
onwards.
Study design and setting
We will perform a randomised controlled multi centre 
study.
This trial is embedded in the Dutch Obstetric Consor­
tium, a collaboration of obstetric hospitals in the Nether­
lands. Approximately 40 hospitals, including all 10 
university hospitals, teaching hospitals and district hospi­
tals will participate in this trial.
Participants/eligibility criteria
All women with a singleton pregnancy, with a child in 
cephalic presentation, with suspicion of IUGR (Fetal 
Abdominal Circumference < 10th centile, Estimated Fetal 
Weight < 10th percentile as defined by local protocols), or 
decreased relative growth though still > 10th centile, e.a. 
from 70th centile to 40th centile) are eligible. Gestational
Page 3 of 6
(page number not for citation purposes)
BMC Pregnancy and Childbirth 2007, 7:12 http://www.biomedcentral.eom/1471 -2393/7/12
age should be between 36+0 weeks and 41+0 weeks. 
Women with a history of caesarean section, serious con­
genital defects, ruptured membranes, renal diseases, dia­
betes mellitus, or positive HIV serology will be excluded.
Procedures, recruitment, randomisation and collection o f  
baseline data
All women with a singleton pregnancy who present at one 
of the participating clinics will be referred to an obstetri­
cian or a specifically appointed research nurse/midwife 
for counselling. Eligible women receive participant infor­
mation. After written consent, they are randomised by 
means of a web-based application. Stratification will be 
applied for previous vaginal birth (nullipara versus multi­
para) and for centre. Randomisation will be in a 1:1 ratio 
for induction of labour or expectant management.
Patients that withhold consent for randomisation are 
asked permission for data collection on pregnancy out­
come. Participation to the quality of life study and long­
term follow up (Child Behavioural Check Lists-CBCL and 
Ages and Stages Questionnaire-ASQ) is asked separately.
Baseline demographic, past obstetric and medical histo­
ries will be recorded for all women. Cervical length will be 
measured at the time of randomisation. The quality of life 
questionnaires are filled out before randomization, after 
randomization, 6 weeks postpartum and 6 months post­
partum. The questionnaires contain the Hospital Anxiety 
and Depression Scale (HADS), EuroQoL 5D3L, Short 
Form (SF-36), Symptom Check List (SCL-90), and ques­
tions on background characteristics, intervention prepar­
edness, risk perception and experience with the current 
pregnancy.
Intervention
When randomised to the induction arm, induction of 
labor must start within 48 hours after randomisation. 
Induction of labor can be proceded according to local pro­
tocol (among other things cervical ripening with prostag- 
landin-gel or tablets or with amniotomy, with or without 
the use of oxytocin). When allocated to the expectant 
management group patients will not be induced unless 
the fetal or maternal condition deteriorates and this is for 
the attending obstetrician a reason for induction. The 
patients will be observed, e.g. with fetal and maternal 
monitoring according to local practice, until labour starts 
spontaneously. However, monitoring must at least 
include measurement of the umbilical artery Doppler 
waveform, fetal heart rate tracing, blood pressure and 
urine analysis for albuminuria weekly. Doppler studies of 
the medial cerebral artery are optional. Reasons for inter­
ventions and time interval between randomisation and 
labour will be collected.
Follow up o f women and infants
All details of delivery, maternal and fetal assessments and 
admittance during pregnancy are recorded in the case 
record form that is accessible at the website. In case of 
admittance of the child to the neonatal intensive care unit, 
details of this admittance are also recorded.
Long-term follow up of children will be done by recording 
growth after birth as measured at the local infant follow 
up clinics.
Outcom e measures
The primary outcome measure will be a bad composite 
neonatal outcome. Adverse neonatal outcome will be 
defined as death before hospital discharge, a 5-minute 
Apgar score < 7, an umbilical artery pH < 7.05 or admis­
sion to the neonatal intensive care. Secondary outcome 
measures are mode of delivery and time until delivery, 
length of admittance at the neonatal intensive care, mater­
nal morbidity, hospitalisation of the m other for fetal and 
maternal surveillance, quality of life, and costs. In the 
present proposal, no funding is asked for long term fol­
low-up of the child, yet. However, if additional funding 
can be obtained children's behavioural-, and neuro devel­
opm ent will assessed by administering with a postal 
enquiry the Child Behaviour Checklist-CBCL and Ages 
and Stages Questionnaire- ASQ by their parents after 2 
years.
Statistical issues
Sample size calculations
The study is designed as an equivalence study, whereby 
both treatments will have the same incidence of the pri­
mary outcome measure of combined bad neonatal out­
come. This incidence is assumed to be 6% [46]. The null 
hypothesis is that both treatments will not be equivalent. 
To detect equivalence with a power of 80% a sample size 
in both groups of 325 will be needed (PASS SOFTWARE). 
The margin of equivalence, given in terms of the differ­
ence, extends from -5.5 % to +5.5 %. The actual difference 
is 0 %. The calculations assume that two, one-sided Z tests 
are used. The significance level of the test is 0.05.
Data  analysis
Data will initially be analysed according to the intention 
to treat method. The m ain outcome variable, 'bad neona­
tal outcome', will be assessed by calculating rates in the 
two groups, relative risks and 95% confidence intervals as 
well as numbers needed to treat.
Time to delivery will be evaluated by Kaplan-Meier esti­
mates, with account for differing durations of gestation at 
entry, and will be tested with the log rank test. The other 
secondary outcome measures will be approached simi­
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larly to the primary outcome measure. The analysis will be 
stratified for parity and centre.
Non response and inclusion bias
As non-response for follow up is overrepresented in cer­
tain outcome-related risk categories such as in non-native 
mothers, mothers with lower educational level and in 
mothers with boys, statistical methods that use imputa­
tion of missing data have to be applied [48]. To prevent 
inclusion bias all patients who were asked but decline ran­
domisation, will be asked for permission to collect data 
on pregnancy outcome and further follow up according to 
the same schedule as the randomised patients.
Econom ic evaluation
The aim of the economic evaluation is to compare opti­
mality, in terms of costs and health effects, of both strate­
gies. As the clinical study is based on equivalence design 
we hypothesize that there will be no relevant difference 
between maternal and neonatal outcome in the two strat­
egies. The economic evaluation will be in the form of a 
cost-effectiveness analysis (CEA), in which the optimal 
strategy is defined as the strategy with the largest health 
gain at the smallest costs.
Ethical considerations
This study has been approved by the ethics committee of 
the Leiden University Medical Centre (Ref. No. P04.210).
Discussion
There is uncertainty about the management of IUGR at 
term, whether to leave the child in utero until spontane­
ous labour starts, or to prevent undernutrition by pro­
longed pregnancy in a poor intra-uterine environment by 
inducing labour. This latter treatment modality will most 
probably be at the cost of an increase in instrumental 
deliveries [46]. As optimal management of a pregnancy at 
term suspected to be complicated by IUGR remains 
unclear, it is a challenge to develop criteria for inducing 
delivery. An increase in fetal surveillance in these pregnan­
cies (with normal umbilical artery studies) is thought to 
be associated with more inductions of labour and a short­
ening of gestational age [49]. Neonatal morbidity (and 
mortality) is low in term SGA neonates [3], nevertheless 
these neonates cannot be considered just "healthy small 
babies".
Although our primary aim is to study pregnancies compli­
cated by IUGR, the inclusion criteria are obviously based 
on a suspicion of a SGA child, as we include women with 
a fetus with a Fetal Abdominal Circumference < 10th cen- 
tile or an Estimated Fetal Weight < 10th centile. By 
patient's characteristics, such as ethnicity, maternal and 
paternal length as well as tests results as the am ount of 
amniotic fluid or the Doppler of the arteria umblicalis, we
will be able to evaluate which pregnancies are at risk for a 
poor neonatal outcome.
In summary, at the present, there is controversy as to 
which strategy is the best when IUGR at term is suspected. 
Whether to induce labour or to await spontaneous labour 
under strict fetal and maternal monitoring remains debat­
able because of a lack of evidence. Patients' management 
partly depends on the attending doctor and on local pro­
tocols. To resolve these issues, we will compare both strat­
egies in the multi centre randomised trial -  DIGITAT. In a 
pilot study carried out in one of the participating hospi­
tals, we examined the feasibility of the DIGITAT-trial. Pre­
liminary data from this small pilot show that the interval 
between randomisation and labour was 2 weeks shorter 
and birth-weight was 100 grams less in the pregnancies 
that were directly terminated by induction [50]. The 
results of the present DIGITAT-trial are expected in 2009.
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